Abstract
Purpose
Standardized reporting in radiology has an established role in numerous disease processes, with added benefits in oncology of reduced variability, and generation of a thorough and pertinent report with a focused and relevant conclusion. Many radiologists are not familiar with the imaging patterns of neuroendocrine neoplasm (NEN) spread and recurrence. This paper will present standardized CT, MRI, and PET templates for reporting gastroenteropancreatic (GEP) NENs and explain the rationale for including specific pertinent positive and negative findings, at various stages of disease management, based on site of origin.
Methods
Basic templates for initial and follow-up anatomic and molecular GEP NEN imaging were created with input from the multidisciplinary Society of Abdominal Radiology (SAR) Neuroendocrine Tumor Disease Focused Panel (NET-DFP). The templates were further modified and finalized after several iterations.
Results
Four main report templates were generated for (i) initial anatomic CT or MR imaging studies, (ii) follow-up anatomic CT or MR imaging studies, (iii) initial Somatostatin Receptor (SSTR) or FDG PET imaging studies, and (iv) follow-up SSTR or FDG PET imaging studies. Each study template was formatted to allow its integration into a dictation software directly and be modified as needed, with internalized instructions indicating where a drop-down menu or macro may be used to personalize the template as necessary.
Conclusion
These templates were created through a combination of multidisciplinary expert opinion discussion supported by literature review and provide basic structured reporting standards for GEP NEN anatomic and molecular imaging studies.
Similar content being viewed by others
References
Xu Z, Wang L, Dai S, Chen M, Li F, Sun J, et al. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States. JAMA Network Open. 2021;4:e2124750–e2124750. doi:https://doi.org/10.1001/jamanetworkopen.2021.24750
Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol. 2017;3:1335–42. doi:https://doi.org/10.1001/jamaoncol.2017.0589
Chan DL, Pavlakis N, Schembri GP, Bernard EJ, Hsiao E, Hayes A, et al. Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance. Theranostics. Ivyspring International Publisher; 2017;7:1149–58. doi: https://doi.org/10.7150/thno.18068
Brook OR, Brook A, Vollmer CM, Kent TS, Sanchez N, Pedrosa I. Structured reporting of multiphasic CT for pancreatic cancer: potential effect on staging and surgical planning. Radiology. United States; 2015;274:464–72. DOI: https://doi.org/10.1148/radiol.14140206
Dimarco M, Cannella R, Pellegrino S, Iadicola D, Tutino R, Allegra F, et al. Impact of structured report on the quality of preoperative CT staging of pancreatic ductal adenocarcinoma: assessment of intra- and inter-reader variability. Abdom Radiol (NY). United States; 2020;45:437–48. https://doi.org/10.1007/s00261-019-02287-7
Hicks RJ, Dromain C, de Herder WW, Costa FP, Deroose CM, Frilling A, et al. ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours. J Neuroendocrinol. United States; 2022;34:e13040. DOI: https://doi.org/10.1111/jne.13040
Dromain C, Vullierme M-P, Hicks RJ, Prasad V, O’Toole D, de Herder WW, et al. ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours. Journal of Neuroendocrinology. John Wiley & Sons, Ltd; 2022;34:e13044. DOI: https://doi.org/10.1111/jne.13044
Kahn CEJ, Langlotz CP, Burnside ES, Carrino JA, Channin DS, Hovsepian DM, et al. Toward best practices in radiology reporting. Radiology. United States; 2009;252:852–6. DOI: https://doi.org/10.1148/radiol.2523081992
Galgano SJ, Iravani A, Bodei L, El-Haddad G, Hofman MS, Kong G. Imaging of Neuroendocrine Neoplasms: Monitoring Treatment Response-AJR Expert Panel Narrative Review. AJR Am J Roentgenol. United States; 2022;1–14. DOI: https://doi.org/10.2214/AJR.21.27159
Krenning E, Valkema R, Kooij P, Breeman W, Bakker W, deHerder W, et al. Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotide. Ital J Gastroenterol Hepatol. 1999;31 Suppl 2:S219-23.
Werner RA, Solnes L, Javadi M, Weich A, Gorin M, Pienta K, et al. SSTR-RADS Version 1.0 as a Reporting System for SSTR-PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization Framework. J Nucl Med. 2018;jnumed.117.206631. DOI: https://doi.org/10.2967/jnumed.117.206631
Kratochwil C, Stefanova M, Mavriopoulou E, Holland-Letz T, Dimitrakopoulou-Strauss A, Afshar-Oromieh A, et al. SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors. Mol Imaging Biol. United States; 2015;17:313–8. DOI: https://doi.org/https://doi.org/10.1007/s11307-014-0795-3
Metser U, Eshet Y, Ortega C, Veit-Haibach P, Liu A, K S Wong R. The association between lesion tracer uptake on 68Ga-DOTATATE PET with morphological response to 177Lu-DOTATATE therapy in patients with progressive metastatic neuroendocrine tumors. Nucl Med Commun. England; 2022;43:73–7. Doi: https://doi.org/10.1097/MNM.0000000000001488
Binderup T, Knigge U, Loft A, Federspiel B, Kjaer A. 18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors. Clin Cancer Res. United States; 2010;16:978–85. DOI: https://doi.org/https://doi.org/10.1158/1078-0432.CCR-09-1759
Ganeshan D, Duong P-AT, Probyn L, Lenchik L, McArthur TA, Retrouvey M, et al. Structured Reporting in Radiology. Acad Radiol. United States; 2018;25:66–73. DOI: https://doi.org/10.1016/j.acra.2017.08.005
Acknowledgements
We thank all members of the Society of Abdominal Radiology (SAR) Neuroendocrine Tumor Disease Focused Panel (NET-DFP) for refining the templates.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests
Authors have no relevant financial disclosures.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Barrs, C., Itani, M., Zulfiqar, M. et al. Gastroenteropancreatic neuroendocrine neoplasm imaging: standard reporting templates. Abdom Radiol 47, 3986–3992 (2022). https://doi.org/10.1007/s00261-022-03677-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-022-03677-0